Verified Nov 2026
Other
·
Whitestown, Indiana
·
Since 1992
PTS Diagnostics manufactures point-of-care diagnostic testing systems for lipid panels, blood glucose, and A1C testing. The company is headquartered in Whitestown, Indiana, was founded in 1992, and employs an estimated 200 to 500 people with estimated revenue of $50 to $100 million. It is a subsidiary of Sinocare and serves the medical, automotive, electric-vehicle, and industrial-equipment industries. Its CardioChek and A1CNow product families are used for cardiovascular and diabetes risk testing in clinics and hospitals.
PTS Diagnostics at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
1992
Headquarters
Whitestown, Indiana
Import activity
26
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
26
Named foreign suppliers
4
Top origins
China · Japan
Shared foreign counterparties do not establish that these companies buy from PTS Diagnostics.
What this tells a buyer
Publicly reported records show PTS Diagnostics announced the closure of a California facility in October 2025, and a product discontinuation notice was reported in May 2026.
The company's listed products include battery-powered portable biometric testing devices, with CardioChek lipid and glucose results reported in about 90 seconds and A1CNow HbA1c results in about 5 minutes.
PTS Diagnostics is a subsidiary of Sinocare rather than an independently listed company, and its estimated size band is 200 to 500 employees.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
PTS Diagnostics manufactures point-of-care diagnostic testing systems for lipid panels, blood glucose, and A1C testing. The company is headquartered in Whitestown, Indiana, was founded in 1992, and employs an estimated 200 to 500 people with estimated revenue of $50 to $100 million. It is a subsidiary of Sinocare and serves the medical, automotive, electric-vehicle, and industrial-equipment industries. Its CardioChek and A1CNow product families are used for cardiovascular and diabetes risk testing in clinics and hospitals.
At a glance
Attribute | Detail |
|---|---|
Founded | 1992 |
Headquarters | Whitestown, Indiana |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
What PTS Diagnostics makes
The company's listed products include battery-powered portable biometric testing devices, with CardioChek lipid and glucose results reported in about 90 seconds and A1CNow HbA1c results in about 5 minutes.
Products and capabilities described on the company's own site include Battery (source: ptsdiagnostics.com).
Trade and customs footprint
Publicly reported records show PTS Diagnostics announced the closure of a California facility in October 2025, and a product discontinuation notice was reported in May 2026. US customs bill-of-lading records list 26 inbound shipments across 4 foreign suppliers, with top origins including China · Japan.
Latest developments
2026-08-06 — Visit Us at ADCES 2026 – Booth 1001 – PTS Diagnostics (ptsdiagnostics.com)
2026-07-02 — A1CNow+ Controls – PTS Diagnostics (ptsdiagnostics.com)
2026-06-16 — We're Hiring: Sales Associate (Washington/Oregon) | PTS Diagnostics (linkedin.com)
2026-05-13 — PTS Diagnostics product discontinuation notice — Pathology & Lab Medicine News | 2D Executive Solutions (pathologygeek.com)
2025-10-09 — PTS Diagnostics to close California facility – Inside INdiana Business (insideindianabusiness.com)
2025-10-08 — PTS Diagnostics, Inc. Announces Planned Closure of California Manufacturing Plant (businesswire.com)
Facilities
PTS Diagnostics is headquartered in Whitestown, Indiana. Public sources also reference these locations:
California — ptsdiagnostics.com
Company details
PTS Diagnostics is a subsidiary of Sinocare rather than an independently listed company, and its estimated size band is 200 to 500 employees. PTS Diagnostics was founded in 1992, has an estimated 200-500 employees, and is headquartered in Whitestown, Indiana.
Frequently asked questions
What does PTS Diagnostics do?
PTS Diagnostics manufactures point-of-care diagnostic testing systems for lipid panels, blood glucose, and A1C testing. The company is headquartered in Whitestown, Indiana, was founded in 1992, and employs an estimated 200 to 500 people with estimated revenue of $50 to $100 million. It is a subsidiary of Sinocare and serves the medical, automotive, electric-vehicle, and industrial-equipment industries. Its CardioChek and A1CNow product families are used for cardiovascular and diabetes risk testing in clinics and hospitals.
Where is PTS Diagnostics headquartered?
PTS Diagnostics is headquartered in Whitestown, Indiana (4600 Anson Blvd, Whitestown, Indiana, 46075).
When was PTS Diagnostics founded?
PTS Diagnostics was founded in 1992.
How big is PTS Diagnostics?
PTS Diagnostics has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Does PTS Diagnostics import from overseas suppliers?
US customs bill-of-lading records show 26 inbound shipments for PTS Diagnostics, with top origins including China · Japan.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.